Diagnosis and management of postpartum hemorrhage
Anesthesia and Pain Medicine
;
: 209-215, 2013.
Article
in Korean
| WPRIM
| ID: wpr-135295
ABSTRACT
Postpartum hemorrhage (PPH) is an important cause of maternal mortality. There is currently no single, satisfactory definition of PPH. The various definitions of PPH may result in delayed diagnosis. Underestimated blood loss concerning PPH is considered one of the biggest problems. The diagnosis of PPH should include proper estimation of blood loss before vital signs and clinical symptoms change. Management of PPH involves early recognition, assessment and resuscitation. Careful monitoring of vital signs, laboratory tests, coagulation testing in particular, and timely diagnosis of the cause of PPH are important. The first priority in the management of PPH is the rapid correction of hypovolemia with fluid infusion and packed red blood cells transfusion, followed by blood component therapy as indicated by the hematocrit, coagulation tests, platelet count and clinical features. Pharmacological management of PPH is to contract uterus (e.g., oxytocin, methylergonovine, 15-methylprostaglandin F2alpha, misoprostol) and to aid hemostasis (e.g., tranexamic acid, recombinant factor VIIa). Surgical management (e.g., balloon tamponade, uterine compression suture, iliac artery ligation) should be considered if hemorrhage persists or vital signs is unstable.
Full text:
Available
Index:
WPRIM (Western Pacific)
Main subject:
Platelet Count
/
Resuscitation
/
Sutures
/
Tranexamic Acid
/
Uterus
/
Blood Transfusion
/
Oxytocin
/
Carboprost
/
Maternal Mortality
/
Hypovolemia
Type of study:
Diagnostic study
Language:
Korean
Journal:
Anesthesia and Pain Medicine
Year:
2013
Type:
Article
Similar
MEDLINE
...
LILACS
LIS